Deep Medicine Acquisition Corp. (DMAQ) Financial Analysis & Valuation | Quarter Chart
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare... more
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect ... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $12.90M | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | Humphrey P. Polanen |
| IPO Date | 2021-12-02 | CAGR | — |
| Employees | 2 | Website | — |
| Div. Yield | — | Payout Ratio | -13% |
| Buy Back Yield | — | Total Yield | — |
DMAQ chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $2.23M | P/E | -22.77 | Forward P/E | — | PEG | — |
| P/S | 0.03 | P/B | 0.57 | P/CF | -0.55 | P/FCF | -0.16 |
| Sales | $20.36M | Sales 1Y | -46.13% | Sales 3Y | 22522.57% | Sales 5Y | — |
| EPS | $-0.13 | EPS 1Y | 61.42% | EPS 3Y | 1187757.14% | EPS 5Y | — |
| Sales QoQ | 7.48% | EPS QoQ | -86.55% | Sales QoQ Avg | 8.13% | EPS QoQ Avg | 41.99% |
| Gross Margin | 50.49% | Operating Margin | -22.58% | Profit Margin | -55.68% | ROCE | -130.29% |
| ROA | -62% | ROE | -294% | Altman Z Score | -2.33 | Piotroski Score | 3 |
| Current Ratio | 0.84 | Quick Ratio | 0.74 | Cash Ratio | 0.44 | Op. CF Ratio | -0.12 |
| Debt/Equity | 1.95 | Debt/Assets | 0.28 | Lt Debt/Equity | 0.07 | Lt Debt/Cap. | 0.12 |
| Intrst Cov. | -6.27 | Inventory Turnover | 7.11 | Asset Turnover | 1.11 | Receivables Turnover | 15.8 |
| Enterprise Value | $2.23M | P/E Ratio | -22.77 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.03 | P/B Ratio | 0.57 |
| P/CF Ratio | -0.55 | P/FCF Ratio | -0.16 |
| EPS | $-0.13 | EPS Growth 1Y | 61.42% |
| EPS Growth 3Y | 1187757.14% | EPS Growth 5Y | — |
| Revenue Growth 1Y | -46.13% | Gross Margin | 50.49% |
| Operating Margin | -22.58% | Profit Margin | -55.68% |
| ROE | -294% | ROA | -62% |
| ROCE | -130.29% | Current Ratio | 0.84 |
| Quick Ratio | 0.74 | Cash Ratio | 0.44 |
| Debt/Equity | 1.95 | Interest Coverage | -6.27 |
| Altman Z Score | -2.33 | Piotroski Score | 3 |
Deep Medicine Acquisition Corp. (DMAQ) valuation & financials
Deep Medicine Acquisition Corp. (DMAQ) has a market capitalization of $12.90M and trades at a price-to-earnings ratio of -22.8. It operates in the Financial Services sector (Shell Companies).
Deep Medicine Acquisition Corp.'s revenue grew -46.1% over the last year.
Compare with other Financial Services companies: Berkshire Hathaway (BRK-B) · JPMorgan Chase (JPM) · Visa (V) · Mastercard (MA) · ICBC (1398.HK) · Agricultural Bank of China (601288.SS)